Jan 7, 2020 07:30AM Nuvo Pharmaceuticals™ Announces Repayment of Bridge Loan and Entitlement to Receive 2019 Vimovo U.S. Annual Minimum Royalty

Aug 14, 2019 07:30AM Nuvo Pharmaceuticals™ Announces 2019 Second Quarter Results

Jul 30, 2019 10:50AM Nuvo Pharmaceuticals™ Provides VIMOVO Patent Update

Jun 26, 2019 07:30AM Nuvo Pharmaceuticals™ Announces Director Election Results of its Annual General Meeting and Updates to the Facility Agreement with Deerfield

Jun 17, 2019 08:00AM Nuvo Pharmaceuticals™ Provides Corporate Update

May 14, 2019 07:00AM Nuvo Pharmaceuticals™ Announces 2019 First Quarter Results

Mar 29, 2019 07:00AM Nuvo Pharmaceuticals™ Announces 2018 Fourth Quarter and Year-End Results

Mar 11, 2019 07:30AM Nuvo Pharmaceuticals™ Announces Receipt of Shareholder Approval By Way of Written Consent For the Issuance of Common Shares Pursuant to Convertible Notes and Warrants

Jan 2, 2019 07:30AM Nuvo Pharmaceuticals™ to Host Conference Call/Audio Webcast to Discuss the Acquisition of Aralez Pharmaceuticals Canada, U.S. and International Rights to Vimovo® and other Related Assets

Dec 31, 2018 11:26AM Nuvo Pharmaceuticals™ Announces Completion of the Acquisition of Aralez Pharmaceuticals Canada, U.S. and International Rights to Vimovo® and other Related Assets

Nov 29, 2018 09:00AM Nuvo Pharmaceuticals™ Declared Winning Bidder to Acquire Commercial Products from Aralez Pharmaceuticals

Nov 8, 2018 07:30AM Nuvo Pharmaceuticals™ Announces 2018 Third Quarter Results

Sep 19, 2018 07:02AM Nuvo Pharmaceuticals™ Announces Signing of Definitive Agreements to Acquire Commercial Products and Infrastructure from Aralez Pharmaceuticals

Aug 20, 2018 07:30AM Nuvo Pharmaceuticals™ Announces Extension of Exclusivity Period with Aralez and Deerfield

Aug 10, 2018 06:19AM Nuvo Pharmaceuticals™ Announces Letter of Intent to Acquire Commercial Products and Infrastructure from Aralez Pharmaceuticals